Format

Send to

Choose Destination
See comment in PubMed Commons below
Magy Onkol. 2003;47(1):45-50. Epub 2003 Apr 18.

[Immuno-diagnosis of malignant melanoma].

[Article in Hungarian]

Author information

1
Hisztopatológia KFT, Hisztopatológai Laboratórium, Pécs, Hungary. histopat@mail.datanet.hu

Abstract

The diagnosis of malignant melanoma must be followed by treatment shown to be effective. Therefore a correct diagnosis, including staging, that will permit a meaningful prognosis and treatment, is essential. The usefulness and great specificity of immunological methods is based on the detection of antigens characteristic of neoplastic and reactive cells. In cases of malignant melanoma, immunohistochemistry has limited practical value in the routine diagnosis of melanocytic lesions. The method may be important, however, in the differential diagnosis of, for example, malignant melanoma vs. non-melanocytic anaplastic neoplasia, malignant vs. benign melanocytic lesions, etc. Recent advances in relating the immunostaining of antigens to the development of tumor cells, such as proliferation and apoptosis, metastatic potential, etc. have given considerable importance to the immunomorphological evaluation of malignant melanomas. Likewise, immunotherapy requires the immunophenotyping of the reactive cells of the immune system.

PMID:
12704454
DOI:
HUON.2003.47.1.0045
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hungarian Oncological Association
    Loading ...
    Support Center